Viewing Study NCT01291394


Ignite Creation Date: 2025-12-25 @ 1:31 AM
Ignite Modification Date: 2026-03-06 @ 8:05 AM
Study NCT ID: NCT01291394
Status: COMPLETED
Last Update Posted: 2017-12-26
First Post: 2011-01-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in France
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Growth Disorders View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Growth disorders View
None Saizen View
None Easypod View
None Growth hormone View
None Pediatric subject View